FATE
Price
$3.88
Change
-$0.34 (-8.06%)
Updated
May 7, 6:59 PM EST
One day until earnings call
GLTO
Price
$0.71
Change
-$0.00 (-0.00%)
Updated
May 7, 6:59 PM EST
84 days until earnings call
Ad is loading...

FATE vs GLTO

Header iconFATE vs GLTO Comparison
Open Charts FATE vs GLTOBanner chart's image
Fate Therapeutics
Price$3.88
Change-$0.34 (-8.06%)
Volume$1.22M
CapitalizationN/A
Galecto
Price$0.71
Change-$0.00 (-0.00%)
Volume$88.28K
CapitalizationN/A
View a ticker or compare two or three
FATE vs GLTO Comparison Chart

Loading...

FATEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GLTODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FATE vs. GLTO commentary
May 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and GLTO is a Hold.

COMPARISON
Comparison
May 08, 2024
Stock price -- (FATE: $3.88 vs. GLTO: $0.71)
Brand notoriety: FATE and GLTO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 76% vs. GLTO: 65%
Market capitalization -- FATE: $441.61M vs. GLTO: $19.25M
FATE [@Biotechnology] is valued at $441.61M. GLTO’s [@Biotechnology] market capitalization is $19.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileGLTO’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • GLTO’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and GLTO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 5 TA indicator(s) are bullish while GLTO’s TA Score has 5 bullish TA indicator(s).

  • FATE’s TA Score: 5 bullish, 5 bearish.
  • GLTO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLTO is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а -1.77% price change this week, while GLTO (@Biotechnology) price change was +5.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.82%. For the same industry, the average monthly price growth was -3.43%, and the average quarterly price growth was +71.42%.

Reported Earning Dates

FATE is expected to report earnings on Jul 31, 2024.

GLTO is expected to report earnings on Jul 31, 2024.

Industries' Descriptions

@Biotechnology (+3.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FATE with price predictions.
OPEN
A.I.dvisor published
a Summary for GLTO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FATE($442M) has a higher market cap than GLTO($19.3M). FATE YTD gains are higher at: 3.743 vs. GLTO (-1.375).
FATEGLTOFATE / GLTO
Capitalization442M19.3M2,290%
EBITDAN/AN/A-
Gain YTD3.743-1.375-272%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATEGLTO
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
72%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
FATEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GLTODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRIEX7.270.03
+0.41%
CRM All Cap Value Inst
ADGRX21.420.08
+0.37%
AB Core Opportunities R
JGMRX23.410.08
+0.34%
Janus Henderson Triton R
JIESX14.830.02
+0.14%
JPMorgan Developed International Value I
LSISX15.930.01
+0.06%
ClearBridge All Cap Value IS

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with PIRS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-8.06%
PIRS - FATE
51%
Loosely correlated
-0.18%
NTLA - FATE
47%
Loosely correlated
+0.67%
ABCL - FATE
47%
Loosely correlated
-1.70%
BEAM - FATE
46%
Loosely correlated
-1.10%
RLAY - FATE
45%
Loosely correlated
-4.53%
More

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been closely correlated with DSGN. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLTO jumps, then DSGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
N/A
DSGN - GLTO
80%
Closely correlated
+28.49%
TCRT - GLTO
56%
Loosely correlated
-1.52%
FATE - GLTO
31%
Poorly correlated
-8.06%
ALT - GLTO
29%
Poorly correlated
-1.22%
MGTX - GLTO
29%
Poorly correlated
+6.22%
More